Investigating Potential Claims: Arrowhead Pharmaceuticals Inc.
Have you suffered investment losses in Arrowhead Pharmaceuticals Inc. at the recommendation of your broker or financial advisor? If so, the securities attorneys at the White Law Group may be able to help you.
Arrowhead Pharmaceuticals, Inc. Reportedly develops medicines that treat intractable diseases by silencing the genes that cause them, according to its website.
According to filings with the SEC, the Arrowhead filed a Form D to raise capital from investors to “fund the company’s operations.” The total offering amount was purportedly $64,000,000, according to the Reg D filing.
The trouble with Reg D private placement investments such as Arrowhead Pharmaceuticals Inc. is that they involve a high degree of risk and are typically sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks and bonds.
Further, Reg D private placements are typically sold by brokerage firms in exchange for a large up-front commission, usually between 7-10%. Private placement investments are also illiquid. It can be difficult to sell your alternative investment since it isn’t traded on any exchange, and if you are able to find a buyer in a secondary market, you may lose money in the sale.
To learn more about the risks of investing in Reg D private placement investments please see: Regulation D Private Placement Fraud Attorneys
File a FINRA Arbitration Claim to Recover Investment Losses
If a brokerage firm makes unsuitable investment recommendations or fails to adequately disclose the risks associated with an investment, they may be liable for investment losses through FINRA arbitration.
FINRA operates the largest securities dispute resolution forum in the United States, and has extensive experience in providing a fair, efficient and effective venue to handle a securities-related dispute.
If you have concerns regarding your investment in Arrowhead Pharmaceuticals Inc. the White Law Group may be able to help you. To speak with a securities attorney about your options, please call the office at 888-637-5510 for a free consultation.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Seattle, Washington.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com. To learn more about the firm’s recent claims involving alternative investments, please see: Centaurus Financial Inc. Lawsuit filed involving High-Risk Alternative Investments
Tags: Arrowhead Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc. lawsuit, Arrowhead Pharmaceuticals Inc. news, Arrowhead Pharmaceuticals Inc. ppm, Arrowhead Pharmaceuticals Inc. private placement, Arrowhead Pharmaceuticals Inc. prospectus, Arrowhead Pharmaceuticals Inc. real estate, Arrowhead Pharmaceuticals Inc. update, Arrowhead Pharmaceuticals Inc. value, Arrowhead Research Corp Last modified: October 26, 2022